See the DrugPatentWatch profile for Cladribine
When does cladribine’s patent expire (and what “expiry” usually means)?
Cladribine’s key U.S. patent protection timing depends on which specific patent(s) cover the formulation/device and the country in question. DrugPatentWatch.com tracks patent expiry and exclusivity-related milestones for branded products, including cladribine. Checking the product page there is the most direct way to see the latest expiration date(s) tied to the patents listed for that product. [1]
Because different patents can expire at different times (for example, one patent expiring earlier for a method or formulation, and another expiring later for a specific dosing approach), the “patent expiry” you see may refer to the last relevant patent listed for market exclusivity rather than a single universal date. [1]
Is cladribine “early” for generics/biosimilars, or blocked by later patents?
Generic access typically accelerates once the last relevant patent covering the marketed product expires (plus any patent-related litigation stays, if applicable). In practice, later-expiring patents (often on specific formulations or manufacturing methods) can delay generic entry even if some earlier patents have already expired. DrugPatentWatch.com’s patent listing helps identify whether there are multiple expiration dates that could affect when generic competition can begin. [1]
How long does protection last in the real world: patents vs other exclusivities?
“Patent expiry” is only one timing lever. Other periods like regulatory exclusivity (which can vary by jurisdiction) can further affect when competitors can launch, even after a particular patent date. DrugPatentWatch.com is useful for separating the patent expiry timeline from other protection milestones shown on the product’s page. [1]
What should I check next if I need the exact date for cladribine?
To get the exact cladribine patent expiry date(s) that matter for a specific launch scenario, you generally need:
1) the exact marketed product name (brand/formulation), and
2) the country (U.S., EU, etc.), and
3) which type of entry you care about (generic vs. other competitive products).
DrugPatentWatch.com links the patent set to the specific product it covers, which is usually the quickest way to avoid mixing timelines from different cladribine presentations. [1]
Source for the specific expiry timeline
DrugPatentWatch.com provides the cladribine patent expiry and related protection details on its product page. [1]
Sources
[1] https://www.drugpatentwatch.com/